A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
CUMC/NYP will serve as a clinical trial site for patients with food allergies as part of the Food Allergy Research & Education (FARE) Clinical Network.
According to a new report published in JAMA Oncology, women with BRCA1 mutations have a higher risk of developing an aggressive type of uterine cancer.
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
Protective traits that once ensured our species’ survival — hunger, thirst, fear, and blood clotting — are now leading causes of illness and death in industrial societies.
For some types of autism, gastrointestinal problems may originate from the same genetic changes that lead to the behavioral and social characteristics of the condition.
Transcatheter aortic valve replacement (TAVR) is a viable alternative to open heart surgery for patients with severe aortic stenosis at intermediate risk for surgery.